Gastrointestinal Perforation Management

Introduction to Gastrointestinal Perforation

Gastrointestinal perforation is a serious condition that requires prompt recognition and treatment, with mortality rates ranging from 15-60%, particularly with multiple perforations, severe peritoneal contamination, delayed presentation, advanced age, and comorbidities, as reported by the World Journal of Emergency Surgery 1

Prolonged duration of ileus, severe distention of bowel loops, underlying bowel pathology, medication use (NSAIDs, steroids, potassium chloride), advanced age, and immunocompromised status are risk factors for small bowel perforation, as stated by the World Journal of Emergency Surgery 1
Medical treatments, including cancer chemotherapy and radiotherapy, are additional risk factors for small bowel perforation 1
Infectious causes, such as typhoid fever, tuberculosis, amoebic infection, Clostridium difficile, cytomegalovirus, and histoplasmosis, can also lead to small bowel perforation, particularly in immunocompromised patients 2, 1

CT scan is the most sensitive imaging modality for detecting free air and determining the location of perforation, as recommended by the American College of Radiology 1
Upright chest X-ray may show free air under the diaphragm, and laboratory studies may reveal leukocytosis and elevated inflammatory markers, according to the World Journal of Emergency Surgery 1

Initial stabilization includes fluid resuscitation, broad-spectrum antibiotics, nasogastric decompression, NPO status, and pain management, as outlined by the Surviving Sepsis Campaign 1
Surgical intervention is the mainstay of treatment, with laparoscopic or open exploration, primary repair, or resection with primary anastomosis, depending on the patient's condition, as recommended by the World Journal of Emergency Surgery 1
The following treatment options are recommended:

The lifetime risk of developing peptic ulcers in individuals infected with H. pylori is approximately 1 in 6 (∼17%) 4
Eradication of H. pylori reduces the recurrence of ulcers from 50-60% to 0-2% 5
Inhibitors of the proton pump (IBP) are fundamental in the treatment of peptic ulcers, and the following recommendations are made:

Early recognition and treatment of ileus, careful monitoring of high-risk patients, judicious use of medications associated with perforation risk, and early surgical consultation when ileus fails to resolve with conservative management are crucial to reducing morbidity and mortality, as recommended by the American College of Surgeons 1
Prognostic factors, such as multiple perforations, severe peritoneal contamination, and delayed presentation, worsen outcomes 1